Renal Denervation Treatment And Device Based Neuromodulation 2Ed (Hb 2023) at Meripustak

Renal Denervation Treatment And Device Based Neuromodulation 2Ed (Hb 2023)

Books from same Author: Heuser R R

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 13677/- [ 11.00% off ]

    Seller Price: ₹ 12172

Sold By: T K Pandey      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Heuser R R
    PublisherSpringer
    Edition2nd Edition
    ISBN9783031389337
    Pages267
    BindingHardcover
    LanguageEnglish
    Publish YearJanuary 2024

    Description

    Springer Renal Denervation Treatment And Device Based Neuromodulation 2Ed (Hb 2023) by Heuser R R

    This extensively revised edition examines renal pathophysiology and the rationale for renal denervation for the management of hypertension, as well as possible long-term benefits and risks of this therapy. Renal denervation is a minimally invasive, endovascular catheter-based procedure that makes use of radiofrequency ablation to treat resistant hypertension, with studies showing a high degree of effectiveness. The devices involved in the continued evolution of this therapy are discussed and the book incorporates analyses of the development of the technique while evaluating its cost effectiveness and future applications.Renal Denervation: A New Approach to Treatment of Resistant Hypertension describes the technique in detail, its advances and its pitfalls. While it has been estimated that 50% of Western civilization has hypertension and approximately 20% of patients have resistant hypertension, hypertension remains the leading cause of cardiovascular morbidity and mortality thus strengthening arguments to consider a wider range of potential solutions to manage these patients.